CHEMICALLY-MODIFIED HUMAN GROWTH HORMONE CONJUGATES

Details for Australian Patent Application No. 2002356990 (hide)

Owner PHARMACIA CORPORATION

Inventors LAO, Wei; SIEGEL, Ned, R.; FINN, Rory, F.

Pub. Number AU-A-2002356990

PCT Number PCT/US02/37270

PCT Pub. Number WO2003/044056

Priority 60/331,907 20.11.01 US

Filing date 20 November 2002

Wipo publication date 10 June 2003

International Classifications

C07K 014/61 Peptides having more than 20 amino acids

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 038/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/331,907 20.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002356990

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002356991-AMINO ACID DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE

2002356989-METHOD AND APPARATUS FOR PROVIDING CALLER ID INFORMATION WITH VOICEMAIL SERVICES SUPPLIED BY THE PHONE COMPANY